Table 1.

Model predicted age-adjusted breast cancer mortality rates in 2004–2006 per 100,000 US women ages 25 years and older

Scenarios	WHITE				BLACK
	MISCAN-Fadia		SPECTRUM		MISCAN-Fadia		SPECTRUM
	Mortality rate per 100,000	Mortality reduction (%) *	Mortality rate per 100,000	Mortality reduction (%) *	Mortality rate per 100,000	Mortality reduction (%) *	Mortality rate per 100,000	Mortality reduction (%) *
No screening or adjuvant therapy	67.0	-	64.0	-	68.2	-	69.5	-
Screening only (as disseminated in the population)	54.6	18.6%	49.9	22.0%	55.9	18.1%	55.5	20.1%
Adjuvant therapy only (as disseminated in the population)	46.3	30.9%	46.4	27.5%	51.7	24.2%	54.3	21.9%
Screening and adjuvant therapy (as disseminated in the population)	37.5	44.0%	37.4	41.4%	41.9	38.6%	43.2	37.8%
Observed mortality rate	36.1				49.8

^*Mortality reductions (%) are calculated by comparing the predicted mortality to the background mortality in the scenario without screening and adjuvant therapy